NEUCYTE
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.
NEUCYTE
Industry:
Biotechnology Health Care Neuroscience Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.neucyte.com
Total Employee:
11+
Status:
Active
Contact:
(650) 274-8199
Email Addresses:
[email protected]
Total Funding:
6.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Founder
Investors List
Leaguer Venture Capital
Leaguer Venture Capital investment in Series A - NeuCyte
Cowin Venture
Cowin Venture investment in Series A - NeuCyte
Wisemont Capital
Wisemont Capital investment in Seed Round - NeuCyte
Official Site Inspections
http://www.neucyte.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "NeuCyte"
Neucyte Translatable Neuroscience
NeuCyte is a biotech company focused on CNS drug discovery. Its SynFire® technology uses human iPSC-derived neurons to identify drug targets, test efficacy, and assess neurotoxicity. …See details»
About Us - NeuCyte, Inc.
NeuCyte is an early-stage biotechnology company solely focused on neurological diseases. With expertise on advancing the drug discovery process by using cell based target-identification and drug-discovery platforms.See details»
NeuCyte - Crunchbase Company Profile & Funding
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization. View contacts for NeuCyte to access new leads …See details»
NeuCyte - LinkedIn
NeuCyte, is an early-stage biotechnology company focused on advancing the drug discovery process by using cell based target-identification and drug-discovery platforms. Our technology...See details»
Neucyte, Inc. Company Profile | Mountain View, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Neucyte, Inc. of Mountain View, CA. Get the latest business insights from Dun & Bradstreet.See details»
NeuCyte - Products, Competitors, Financials, Employees, …
NeuCyte is an innovative biotechnology company focused on CNS drug discovery. The company offers a proprietary in vitro platform using human iPSC-derived neurons for target …See details»
NeuCyte - Org Chart, Teams, Culture & Jobs | The Org
View NeuCyte's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
NeuCyte Company Profile - Office Locations, Competitors ... - Craft
NeuCyte is a biotechnology company focused on neurological diseases. It develops solutions to accelerate and optimize CNS (central nervous system) drug discovery. Its human neural …See details»
Team (All) | NeuCyte, Inc.
Dominique Lessard is the Head of Business Development at NeuCyte where she applies her expertise in network growth and development, science communication, and science-driven advocacy to lead outreach efforts and …See details»
NeuCyte Company Profile 2024: Valuation, Funding & Investors
Developer of target-identification and drug-discovery platform designed to create impactful medicines for the treatment of neurological disorders.See details»
NeuCyte - Funding, Financials, Valuation & Investors - Crunchbase
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.See details»
NeuCyte and Mount Sinai Enter Collaboration Agreement - PR …
SAN CARLOS, Calif., Jan. 19, 2021 /PRNewswire/ -- NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today announced …See details»
NeuCyte Joins KIF1A.ORG’s Mission to Accelerate Therapeutic …
Aug 19, 2021 · NeuCyte immediately stood out as a high-performing biotechnology company with the capabilities and experience we need. Specializing in neurological diseases and drug …See details»
Drug Discovery | NeuCyte, Inc.
At NeuCyte we are working to make a difference in the lives of people suffering with neurological disorders. Our unique technology allows us to develop human neural in vitro disease models …See details»
Neucyte - VentureRadar
NeuCyte, is an early-stage biotechnology company focused on advancing the drug discovery process by using cell based target-identification and drug-discovery platforms. The company's …See details»
Neucyte Translatable Neuroscience
NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today announced that it has entered into a research collaboration …See details»
NeuCyte and KIF1A.ORG Enter Collaboration Agreement - Newswire
Aug 17, 2021 · NeuCyte is joining the KIF1A.ORG community in its search for a treatment and cure for KIF1A-Associated Neurological Disorder (KAND). KAND is a progressive and …See details»
KIF1A.ORG Collaboration Agreement | NeuCyte, Inc.
Aug 17, 2021 · San Carlos, California, USA, August 17th, 2021 – NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today …See details»
NeuCyte and KIF1A.ORG Enter Collaboration Agreement - PR …
Aug 17, 2021 · NeuCyte is joining the KIF1A.ORG community in its search for a treatment and cure for KIF1A-Associated Neurological Disorder (KAND). KAND is a progressive and …See details»